Zhonghua wai ke za zhi [Chinese journal of surgery] · 1998
[Reoperation for recurrent carcinoma of the esophagus and cardia].
Аннотация на английскомСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wei G, Shao L, Liu X, Gao J, Xu J, Xing W
Аннотация
OBJECTIVE: To review the experience of reoperation for recurrent carcinoma of the esophagus and cardia.
METHOD: Between 1979 and 1996, 44 patients with recurrent esophageal and cardiac cancer after the first operation underwent reoperation. Among them, 21 had esophageal cancer and 23 cardiac cancer. 36 patients were male and 8 female, with age ranged from 42 to 68 years.
RESULT: The resectability rate was 77.2% (34/44) and the hospital mortality rate was 5.8%. Postoperative complications occurred in 7 patients with a morbidity of 20.5%. Pathologically, previous anastomotic relapse was seen in 26 patients, recurrent lesion of residual esophagus in 7, and recurrent cancerous residue at the esophageal bed in 1. 15 patients (44%) showed lymph node metastasis. Follow-up showed that 4 patients survived for 5 years, 4 for 3 years, and 3 for 2 years. 15 patients died within one year after reoperation.
CONCLUSION: The recurrence of esophageal and cardiac cancer after first operation is not a contraindication to reoperation, but careful preoperative assessment and patients' selection should become an integral part of the evaluation of these patients.
METHOD: Between 1979 and 1996, 44 patients with recurrent esophageal and cardiac cancer after the first operation underwent reoperation. Among them, 21 had esophageal cancer and 23 cardiac cancer. 36 patients were male and 8 female, with age ranged from 42 to 68 years.
RESULT: The resectability rate was 77.2% (34/44) and the hospital mortality rate was 5.8%. Postoperative complications occurred in 7 patients with a morbidity of 20.5%. Pathologically, previous anastomotic relapse was seen in 26 patients, recurrent lesion of residual esophagus in 7, and recurrent cancerous residue at the esophageal bed in 1. 15 patients (44%) showed lymph node metastasis. Follow-up showed that 4 patients survived for 5 years, 4 for 3 years, and 3 for 2 years. 15 patients died within one year after reoperation.
CONCLUSION: The recurrence of esophageal and cardiac cancer after first operation is not a contraindication to reoperation, but careful preoperative assessment and patients' selection should become an integral part of the evaluation of these patients.